Cargando…
Supraphysiological levels of GDF11 induce striated muscle atrophy
Growth and differentiation factor (GDF) 11 is a member of the transforming growth factor β superfamily recently identified as a potential therapeutic for age‐related cardiac and skeletal muscle decrements, despite high homology to myostatin (Mstn), a potent negative regulator of muscle mass. Though...
Autores principales: | Hammers, David W, Merscham‐Banda, Melissa, Hsiao, Jennifer Ying, Engst, Stefan, Hartman, James J, Sweeney, H Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376753/ https://www.ncbi.nlm.nih.gov/pubmed/28270449 http://dx.doi.org/10.15252/emmm.201607231 |
Ejemplares similares
-
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy
por: Roy, Anirban, et al.
Publicado: (2022) -
The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury
por: Rybalko, Viktoriya, et al.
Publicado: (2015) -
A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice
por: Jin, Quan, et al.
Publicado: (2019) -
FILAMENT LENGTHS IN STRIATED MUSCLE
por: Page, Sally G., et al.
Publicado: (1963) -
Autophagy in striated muscle diseases
por: Li, Haiwen, et al.
Publicado: (2022)